Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma

Biggar, R. J., Johansen, J. S., Smedby, K. E., Rostgaard, K., Chang, E. T., Adami, H.-O., Glimelius, B., Molin, D., Hamilton-Dutoit, S., Melbye, M., & Hjalgrim, H. (2008) Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma. Clinical Cancer Research, 14(21), p. 6974.

View at publisher (open access)

Abstract

Purpose Serum levels of the inflammatory markers YKL-40 and IL-6 are increased in many conditions, including cancers. We examined serum YKL-40 and IL-6 levels in patients with Hodgkin lymphoma (HL), a tumor with strong immunologic reaction to relatively few tumor cells, especially in nodular sclerosis HL. Experimental Design We analyzed Danish and Swedish patients with incident HL (N=470) and population controls from Denmark (N= 245 for YKL-40; N= 348 for IL-6). Serum YKL-40 and IL-6 levels were determined by ELISA, and log-transformed data were analysed by linear regression, adjusting for age and sex. Results Serum levels of YKL-40 and IL-6 were increased in HL patients compared to controls (YKL-40: 3.6-fold, IL-6: 8.3-fold; both p<0.0001). In samples from pre-treatment HL patients (N=176), levels were correlated with more advanced stages (ptrend 0.0001 for YKL-40 and 0.013 for IL-6) and in those with B symptoms, but levels were similar in nodular sclerosis and mixed cellularity subtypes, by EBV status, and in younger (<45 years old) and older patients. Patients tested soon after treatment onset had significantly lower levels than pre-treatment patients, but even >6 months after treatment onset, serum YKL-40 and IL-6 levels remained significantly increased, compared to controls. In patients who died (N=12), pre-treatment levels for both YKL-40 and IL-6 were higher than in survivors, although not statistically significantly. Conclusions Serum YKL-40 and IL-6 levels were increased in untreated HL patients and those with more advanced stages but did not differ significantly by HL histology. Following treatment, serum levels were significantly lower.

Impact and interest:

32 citations in Scopus
Search Google Scholar™
34 citations in Web of Science®

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 49769
Item Type: Journal Article
Refereed: Yes
Additional URLs:
ISSN: 1078-0432
Divisions: Current > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: American Association for Cancer Research
Deposited On: 18 Apr 2012 04:46
Last Modified: 18 Apr 2012 04:46

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page